Illumina, Inc. (ILMN): are the analysts right?

Illumina, Inc. · Health Care · ref. ETF XLV · 120 calls · price $177.31
What the company does: Illumina fournit des solutions de séquençage et d'analyse génétique et génomique dans le monde.
📈 1-year price
$191.76+93.2% over range
Jul 8, 25low $91 · high $194.33Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
56% recommend buying · 9 analysts
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.

🎯 Analyst price target on ILMN

High target · 2 analysts$185+4.3%
Median target · 9 analysts$155-12.6%
Low target · 1 analyst$95-46.4%
Current price$177.31

🗳️ The analyst consensus

Analyst breakdown · 9 (6 months)
Strong Buy0%
Buy56%
Hold22%
Sell22%
Strong Sell0%

✅ Historical analyst reliability on ILMN

Most reliable analysts on ILMN (% profitable · 365j · ≥2 calls)
Guggenheim 100% +33.9% 5
Argus Research 50% +9.1% 6
Tigress Financial 50% +4.7% 2
Barclays 50% +1.4% 12
Stephens & Co. 38% -1.3% 8
Piper Sandler 33% -5.4% 12
Evercore ISI Group 33% -5.7% 6
RBC Capital 33% -8.2% 12
Canaccord Genuity 18% -13.7% 11
HSBC 0% -31.6% 2

📊 What $1,000 invested in Illumina, Inc. would be worth

In short — $1,000 invested in Illumina, Inc. 10 years ago would be worth $942 today, i.e. -1%/yr on average. Best year: 2017 (+71%), worst: 2022 (-47%). Price performance, excluding dividends.

If I'd invested $1,000 in Illumina, Inc.

InvestmentWorth todayGain
1 years ago$1,316+32%
3 years ago$894-11%
5 years ago$489-51%
10 years ago$942-6%
since inception (2000)$8,078+708%

Return by year (Illumina, Inc.)

YearReturn$1,000 invested at year start
2026 (YTD)+34%$1,341 (+34%)
2025-2%$1,316 (+32%)
2024-1%$1,298 (+30%)
2023-31%$894 (-11%)
2022-47%$475 (-52%)
2021+3%$489 (-51%)
2020+12%$545 (-46%)
2019+11%$603 (-40%)
2018+37%$827 (-17%)
2017+71%$1,412 (+41%)
2016-33%$942 (-6%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on ILMN

Barclays
Jun 24, 26
▼ Underweight · 🎯$145
Price at call : $177.65 — upside -18%
Today : $177.31 — upside -18%
🎯 on ILMN : 50% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Jun 24, 27
JP Morgan
Jun 10, 26
▲ Overweight · 🎯$185
Price at call : $162.47 — upside +14%
Today : $177.31 — upside +4%
🎯 on ILMN : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Jun 10, 27
Guggenheim
Jun 1, 26
▲ Buy · 🎯$180
Price at call : $164.4 — upside +9%
Today : $177.31 — upside +2%
🎯 on ILMN : 100% (5 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
in progress (365j)
matures : Jun 1, 27
Citigroup
May 4, 26
▼ Sell · 🎯$95
Price at call : $139.07 — upside -32%
Today : $177.31 — upside -46%
🎯 on ILMN : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : May 4, 27
■ Hold neutral · not a buy · 🎯$140
Price at call : $139.37 — gap to target +0%
Today : $177.31 — gap to target -21%
🎯 on ILMN : 18% (11 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : May 2, 27
JP Morgan
May 1, 26
■ Neutral neutral · not a buy · 🎯$125
Price at call : $139.37 — gap to target -10%
Today : $177.31 — gap to target -30%
🎯 on ILMN : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : May 1, 27
Barclays
May 1, 26
▼ Underweight · 🎯$122
Price at call : $139.37 — upside -12%
Today : $177.31 — upside -31%
🎯 on ILMN : 50% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : May 1, 27
▲ Outperform · 🎯$155
Price at call : $135.78 — upside +14%
Today : $177.31 — upside -13%
🎯 on ILMN : 33% (6 calls matureds) · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : May 1, 27
▲ Overweight · 🎯$170
Price at call : $119.32 — upside +42%
Today : $177.31 — upside -4%
🎯 on ILMN : 33% (12 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Feb 9, 27
JP Morgan
Feb 6, 26
■ Neutral neutral · not a buy · 🎯$120
Price at call : $117.25 — gap to target +2%
Today : $177.31 — gap to target -32%
🎯 on ILMN : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Feb 6, 27
Guggenheim
Jan 26, 26
▲ Buy · 🎯$170
Price at call : $152.09 — upside +12%
Today : $177.31 — upside -4%
🎯 on ILMN : 100% (5 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
in progress (365j)
matures : Jan 26, 27
■ Hold neutral · not a buy · 🎯$150
Price at call : $153 — gap to target -2%
Today : $177.31 — gap to target -15%
🎯 on ILMN : 18% (11 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : Jan 26, 27
Stifel
Jan 20, 26
▲ Buy · 🎯$155
Price at call : $152.48 — upside +2%
Today : $177.31 — upside -13%
🎯 on ILMN : no call matured yet · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Jan 20, 27
TD Cowen
Jan 7, 26
■ Hold neutral · not a buy · 🎯$140
Price at call : $145.83 — gap to target -4%
Today : $177.31 — gap to target -21%
🎯 on ILMN : no call matured yet · 📊 on Health : 61.9% · +26.8% (21 calls)
in progress (365j)
matures : Jan 7, 27
Guggenheim
Jan 5, 26
▲ Buy · 🎯$144
Price at call : $147.11 — upside -2%
Today : $177.31 — upside -19%
🎯 on ILMN : 100% (5 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
in progress (365j)
matures : Jan 5, 27
■ Hold neutral · not a buy · 🎯$130
Price at call : $137.6 — gap to target -6%
Today : $177.31 — gap to target -27%
🎯 on ILMN : 18% (11 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : Dec 22, 26
Barclays
Dec 15, 25
▼ Underweight · 🎯$110
Price at call : $131.56 — upside -16%
Today : $177.31 — upside -38%
🎯 on ILMN : 50% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Dec 15, 26
JP Morgan
Dec 15, 25
■ Neutral neutral · not a buy · 🎯$130
Price at call : $131.56 — gap to target -1%
Today : $177.31 — gap to target -27%
🎯 on ILMN : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Dec 15, 26
Barclays
Oct 31, 25
▼ Underweight · 🎯$100
Price at call : $119.99 — upside -17%
Today : $177.31 — upside -44%
🎯 on ILMN : 50% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Oct 31, 26
■ Hold neutral · not a buy · 🎯$112
Price at call : $119.99 — gap to target -7%
Today : $177.31 — gap to target -37%
🎯 on ILMN : 18% (11 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : Oct 31, 26
JP Morgan
Oct 31, 25
■ Neutral neutral · not a buy · 🎯$105
Price at call : $119.99 — gap to target -12%
Today : $177.31 — gap to target -41%
🎯 on ILMN : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Oct 31, 26
TD Cowen
Oct 31, 25
■ Hold neutral · not a buy · 🎯$115
Price at call : $119.99 — gap to target -4%
Today : $177.31 — gap to target -35%
🎯 on ILMN : no call matured yet · 📊 on Health : 61.9% · +26.8% (21 calls)
in progress (365j)
matures : Oct 31, 26
UBS
Oct 31, 25
■ Neutral neutral · not a buy · 🎯$120
Price at call : $119.99 — gap to target +0%
Today : $177.31 — gap to target -32%
🎯 on ILMN : no call matured yet · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Oct 31, 26
Baird
Oct 31, 25
■ Neutral neutral · not a buy · 🎯$109
Price at call : $119.99 — gap to target -9%
Today : $177.31 — gap to target -39%
🎯 on ILMN : no call matured yet · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : Oct 31, 26
▲ Outperform · 🎯$142
Price at call : $123.54 — upside +15%
Today : $177.31 — upside -20%
🎯 on ILMN : 33% (6 calls matureds) · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Oct 31, 26
▲ Outperform · 🎯$132
Price at call : $97.78 — upside +35%
Today : $177.31 — upside -26%
🎯 on ILMN : 33% (6 calls matureds) · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Oct 7, 26
Barclays
Oct 2, 25
▼ Underweight · 🎯$95
Price at call : $102.12 — upside -7%
Today : $177.31 — upside -46%
🎯 on ILMN : 50% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Oct 2, 26
■ Equal-Weight neutral · not a buy · 🎯$105
Price at call : $97.76 — gap to target +7%
Today : $177.31 — gap to target -41%
🎯 on ILMN : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Aug 4, 26
RBC Capital
Aug 1, 25
▲ Outperform · 🎯$126
Price at call : $98.44 — upside +28%
Today : $177.31 — upside -29%
🎯 on ILMN : 33% (12 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Aug 1, 26
■ Hold neutral · not a buy · 🎯$105
Price at call : $98.44 — gap to target +7%
Today : $177.31 — gap to target -41%
🎯 on ILMN : 18% (11 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : Aug 1, 26
JP Morgan
Aug 1, 25
■ Neutral neutral · not a buy · 🎯$100
Price at call : $98.44 — gap to target +2%
Today : $177.31 — gap to target -44%
🎯 on ILMN : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Aug 1, 26
UBS
Aug 1, 25
■ Neutral neutral · not a buy · 🎯$110
Price at call : $98.44 — gap to target +12%
Today : $177.31 — gap to target -38%
🎯 on ILMN : no call matured yet · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Aug 1, 26
Barclays
Aug 1, 25
▼ Underweight · 🎯$90
Price at call : $94.66 — upside -5%
Today : $177.31 — upside -49%
🎯 on ILMN : 50% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Aug 1, 26
Baird
Jul 28, 25
■ Neutral neutral · not a buy · 🎯$105
Price at call : $109.88 — gap to target -4%
Today : $177.31 — gap to target -41%
🎯 on ILMN : no call matured yet · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : Jul 28, 26
Scotiabank
Jul 11, 25
■ Sector Perform neutral · not a buy · 🎯$125
Price at call : $99.25 — gap to target +26%
Today : $177.31 — gap to target -30%
🎯 on ILMN : no call matured yet · 📊 on Health : 0% · -10.9% (4 calls)
in progress (365j)
matures : Jul 11, 26
Citigroup
Jul 9, 25
▼ Sell · 🎯$80
Price at call : $97.44 — upside -18%
Today : $177.31 — upside -55%
🎯 on ILMN : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Jul 9, 26
▲ Outperform · 🎯$128
Price at call : $99.27 — upside +29%
Today : $177.31 — upside -28%
🎯 on ILMN : 33% (6 calls matureds) · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Jul 8, 26
Barclays
Jun 24, 25
▼ Underweight · 🎯$85
Price at call : $93.23 — upside -9%
Today : $177.31 — upside -52%
Expected -9% · Actual +91% · Reason (≤ −15%) : ✗ No
🎯 on ILMN : 50% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-90.5%
stock +91% · XLV +16%
■ Hold neutral · not a buy · 🎯$99
Price at call : $87.54 — gap to target +13%
Today : $177.31 — gap to target -44%
🎯 on ILMN : 18% (11 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : Jun 11, 26
▲ Overweight · 🎯$105
Price at call : $84.21 — upside +25%
Today : $177.31 — upside -41%
Expected +25% · Actual +69% · Reason (≥ +15%) : ✓ Yes
🎯 on ILMN : 38% (8 calls matureds) · 📊 on Health : 62.2% · +10.1% (37 calls)
+68.5%
stock +69% · XLV +9%
Piper Sandler
May 15, 25
▲ Overweight · 🎯$185
Price at call : $83.62 — upside +121%
Today : $177.31 — upside +4%
Expected +121% · Actual +69% · Reason (≥ +15%) : ✓ Yes
🎯 on ILMN : 33% (12 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)
+69.2%
stock +69% · XLV +9%
■ Equal-Weight neutral · not a buy · 🎯$100
Price at call : $80.3 — gap to target +25%
Today : $177.31 — gap to target -44%
🎯 on ILMN : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : May 12, 26
■ Hold neutral · not a buy · 🎯$87
Price at call : $81.57 — gap to target +7%
Today : $177.31 — gap to target -51%
🎯 on ILMN : 18% (11 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : May 12, 26
JP Morgan
May 9, 25
■ Neutral neutral · not a buy · 🎯$85
Price at call : $81.57 — gap to target +4%
Today : $177.31 — gap to target -52%
🎯 on ILMN : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : May 9, 26
Guggenheim
May 9, 25
▲ Buy · 🎯$114
Price at call : $81.57 — upside +40%
Today : $177.31 — upside -36%
Expected +40% · Actual +75% · Reason (≥ +15%) : ✓ Yes
🎯 on ILMN : 100% (5 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
+74.7%
stock +75% · XLV +5%
■ Hold neutral · not a buy · 🎯$92
Price at call : $77.1 — gap to target +19%
Today : $177.31 — gap to target -48%
🎯 on ILMN : 18% (11 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : Apr 29, 26
Barclays
Apr 10, 25
▼ Underweight · 🎯$77
Price at call : $74.78 — upside +3%
Today : $177.31 — upside -57%
Expected +3% · Actual +70% · Reason (≤ −15%) : ✗ No
🎯 on ILMN : 50% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-69.8%
stock +70% · XLV +8%
RBC Capital
Apr 8, 25
▲ Outperform · 🎯$112
Price at call : $76.3 — upside +47%
Today : $177.31 — upside -37%
Expected +47% · Actual +62% · Reason (≥ +15%) : ✓ Yes
🎯 on ILMN : 33% (12 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+62.1%
stock +62% · XLV +8%
Citigroup
Apr 7, 25
■ Neutral neutral · not a buy · 🎯$85
Price at call : $70.3 — gap to target +21%
Today : $177.31 — gap to target -52%
🎯 on ILMN : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Apr 7, 26
RBC Capital
Mar 12, 25
▲ Outperform · 🎯$128
Price at call : $84.05 — upside +52%
Today : $177.31 — upside -28%
Expected +52% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on ILMN : 33% (12 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+41.5%
stock +42% · XLV +4%
▲ Overweight · 🎯$156
Price at call : $84.2 — upside +85%
Today : $177.31 — upside -12%
Expected +85% · Actual +37% · Reason (≥ +15%) : ✓ Yes
🎯 on ILMN : 38% (8 calls matureds) · 📊 on Health : 62.2% · +10.1% (37 calls)
+37.2%
stock +37% · XLV +4%
Piper Sandler
Feb 10, 25
▲ Overweight · 🎯$190
Price at call : $100.68 — upside +89%
Today : $177.31 — upside +7%
Expected +89% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on ILMN : 33% (12 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)
+15.6%
stock +16% · XLV +7%
Barclays
Feb 10, 25
▼ Underweight · 🎯$100
Price at call : $104.99 — upside -5%
Today : $177.31 — upside -44%
Expected -5% · Actual +14% · Reason (≤ −15%) : ✗ No
🎯 on ILMN : 50% (12 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-13.7%
stock +14% · XLV +6%
RBC Capital
Feb 7, 25
▲ Outperform · 🎯$247
Price at call : $104.99 — upside +135%
Today : $177.31 — upside +39%
Expected +135% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on ILMN : 33% (12 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+11.7%
stock +12% · XLV +7%
Guggenheim
Feb 7, 25
▲ Buy · 🎯$150
Price at call : $104.99 — upside +43%
Today : $177.31 — upside -15%
Expected +43% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on ILMN : 100% (5 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
+11.7%
stock +12% · XLV +7%
▲ Overweight · 🎯$184
Price at call : $147.62 — upside +25%
Today : $177.31 — upside +4%
Expected +25% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on ILMN : 38% (8 calls matureds) · 📊 on Health : 62.2% · +10.1% (37 calls)
-17.4%
stock -17% · XLV +4%
Piper Sandler
Nov 11, 24
▲ Overweight · 🎯$185
Price at call : $151.5 — upside +22%
Today : $177.31 — upside +4%
Expected +22% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on ILMN : 33% (12 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)
-19.1%
stock -19% · XLV +1%
RBC Capital
Nov 5, 24
▲ Outperform · 🎯$254
Price at call : $151.83 — upside +67%
Today : $177.31 — upside +43%
Expected +67% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on ILMN : 33% (12 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-20.2%
stock -20% · XLV -1%
▲ Outperform · 🎯$200
Price at call : $146.07 — upside +37%
Today : $177.31 — upside +13%
Expected +37% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on ILMN : 0% (1 call matured) · 📊 on Health : 44.4% · -4.7% (9 calls)
-31.9%
stock -32% · XLV -5%
HSBC
Oct 17, 24
▲ Buy · 🎯$180
Price at call : $143.52 — upside +25%
Today : $177.31 — upside +2%
Expected +25% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on ILMN : 0% (2 calls matureds) · 📊 overall : 38.5% · -3.5% (26 calls)
-33.5%
stock -33% · XLV -6%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)